Source:http://linkedlifedata.com/resource/pubmed/id/20095577
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2010-2-19
|
pubmed:abstractText |
P2Y nucleotide receptors (P2Y-Rs) play important physiological roles. However, most of the P2Y-R subtypes are still lacking potent and selective agonists and antagonists. Based on data mining analysis of binding interactions in 44 protein-uridine nucleos(t)ides complexes, we designed uracil nucleotides, substituted at the C5/C6 position. All C6-substituted derivatives were inactive at the P2Y(2,4,6)-Rs, while out of the C5-substituted analogues, only 5-OMe-UD(T)P showed activity. To rationalize the data, the ionization and conformation of these analogues were evaluated. The pK(a) values of most analogues substituted at the C5/C6 positions were unaltered compared to UTP (pK(a) 9.42), except for 5-F-UTP nucleotide (pK(a) 7.85). C6-substituted analogues adopt the syn or high-syn conformations, which are disfavored by the receptors, while 5-OMe-UD(T)P adopt the favored anti conformation. Furthermore, 5-OMe-UDP adopts the S sugar puckering, which is the conformation preferred by the P2Y(6)-R, but not the P2Y(2)- or P2Y(4)-Rs. 5-OMe-UDP fulfills the conformational and H-bonding requirements of P2Y(6)-R, thus, making a potent P2Y(6)-R agonist (EC(50) 0.08 microM), more than UDP (EC(50) 0.14 microM).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Ligands,
http://linkedlifedata.com/resource/pubmed/chemical/Purinergic P2 Receptor Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Purinergic P2,
http://linkedlifedata.com/resource/pubmed/chemical/Uridine Diphosphate,
http://linkedlifedata.com/resource/pubmed/chemical/purinoceptor P2Y6
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1520-4804
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
25
|
pubmed:volume |
53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1673-85
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:20095577-Calcium,
pubmed-meshheading:20095577-Cell Line, Tumor,
pubmed-meshheading:20095577-Humans,
pubmed-meshheading:20095577-Ligands,
pubmed-meshheading:20095577-Magnetic Resonance Spectroscopy,
pubmed-meshheading:20095577-Molecular Conformation,
pubmed-meshheading:20095577-Purinergic P2 Receptor Agonists,
pubmed-meshheading:20095577-Receptors, Purinergic P2,
pubmed-meshheading:20095577-Structure-Activity Relationship,
pubmed-meshheading:20095577-Transfection,
pubmed-meshheading:20095577-Uridine Diphosphate
|
pubmed:year |
2010
|
pubmed:articleTitle |
5-OMe-UDP is a potent and selective P2Y(6)-receptor agonist.
|
pubmed:affiliation |
Department of Chemistry, Gonda-Goldschmied Medical Research Center, Bar-Ilan University, Ramat-Gan 52900, Israel.
|
pubmed:publicationType |
Journal Article
|